Indications
Therapeutic Asset Ratings
6,299 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Tiragolumab
Atypical Teratoid Rhabdoid Tumor
National Cancer Institute (NCI)
P1/2
CC
(45)
Tiragolumab
Poorly Differentiated Chordoma
National Cancer Institute (NCI)
P1/2
CC
(45)
Tiragolumab
Chordoma
National Cancer Institute (NCI)
P1/2
CC
(45)
Tislelizumab
Breast Neoplasm
BriaCell Therapeutics Corporation
P1/2
CC
(45)
Tislelizumab
Lung Neoplasm
Novartis Pharmaceuticals
P1/2
CC
(45)
Tivozanib
Bile Duct Cancer
University of Florida
P1/2
CC
(45)
Tivozanib
Gallbladder Cancer
University of Florida
P1/2
CC
(45)
Tivozanib
Vulva Cancer
University of Florida
P1/2
CC
(45)
tng260
Lung Adenocarcinoma
Tango Therapeutics, Inc.
P1/2
CC
(45)
tng348
Breast-Ovarian Cancer, Familial, Susceptibility To, 1
Tango Therapeutics, Inc.
P1/2
CC
(45)
tng456
Brain Neoplasm
Tango Therapeutics, Inc.
P1/2
CC
(45)
tng456
Malignant Glioma
Tango Therapeutics, Inc.
P1/2
CC
(45)
tng462
Malignant Pancreatic Neoplasm
Tango Therapeutics, Inc.
P1/2
CC
(45)
tng462
Pancreatic Ductal Adenocarcinoma
Tango Therapeutics, Inc.
P1/2
CC
(45)
tng462
Thoracic Cancer
Tango Therapeutics, Inc.
P1/2
CC
(45)
tno155
Lung Cancer
Novartis Pharmaceuticals
P1/2
CC
(45)
tno155
Colorectal Carcinoma
Novartis Pharmaceuticals
P1/2
CC
(45)
tno155
Lung Neoplasm
Novartis Pharmaceuticals
P1/2
CC
(45)
Tocilizumab
Ovarian Serous Adenocarcinoma
Regeneron Pharmaceuticals
P1/2
CC
(45)
Tocilizumab
Nasopharyngeal Carcinoma
Takeda
P1/2
CC
(45)
tqb2618
Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
P1/2
CC
(45)
Transcon Il-2 Β/Γ
Ovarian Cancer
Ascendis Pharma Oncology Division A/S
P1/2
CC
(45)
Transcon Tlr7/8 Agonist
Small Cell Lung Carcinoma
Ascendis Pharma Oncology Division A/S
P1/2
CC
(45)
Transcon Tlr7/8 Agonist
HER2 Positive Breast Carcinoma
Ascendis Pharma Oncology Division A/S
P1/2
CC
(45)
Trifluridine/Tipiracil Hydrochloride Combination Agent Tas-102
Malignant Pancreatic Neoplasm
Oncolytics Biotech
P1/2
CC
(45)
Showing 3876 to 3900 of 6,299 assets
Previous
Page 156 of 252
Next